Aggressive Simultaneous Radiochemotherapy with Cisplatin and Paclitaxel in Combination with Accelerated Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Tumors

Thomas Kuhnt(Leipzig University), Jürgen Dunst(University Hospital Schleswig-Holstein), Tanja Pelz(Martin Luther University Halle-Wittenberg), Gabriele Hänsgen(Martin Luther University Halle-Wittenberg), M Passmann(Martin Luther University Halle-Wittenberg), Marc Bloching(Luther University), Steffi Pigorsch(Technical University of Munich), Axel Becker(Martin Luther University Halle-Wittenberg), Erwin Lotterer(Martin Luther University Halle-Wittenberg)
Strahlentherapie und Onkologie
October 1, 2003
10.1007/s00066-003-1106-0
Cited by 30

Related Papers

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|369
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
|BMJ|2020|293
Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas
|International Journal of Radiation Oncology*Biology*Physics|2000|218
Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis
|International Journal of Radiation Oncology*Biology*Physics|2003|197